Effects of smoking, depression, and anxiety on mortality in COPD patients: A prospective study

Respiratory Care

Volumn 59, Issue 1, 2014, Pages 54-61

  Lou, Peian ^a   Chen, Peipei ^a   Zhang, Pan ^a   Yu, Jiaxi ^a   Wang, Yong ^a   Chen, Na ^a   Zhang, Lei ^a   Wu, Hongmin ^a   Zhao, Jing ^a  

^a Xuzhou Center for Disease Control and Prevention   (China)

Author keywords

Anxiety; COPD; Death; Depression; Interaction; Smoking

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ANXIETY; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEATH; DEPRESSION; DISEASE ASSOCIATION; DYSPNEA; EXERCISE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY; RISK; SENSITIVITY ANALYSIS; SMOKING;

ANXIETY; COPD; DEATH; DEPRESSION; INTERACTION; SMOKING;

AGED; AGED, 80 AND OVER; ANXIETY; CHINA; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 84891473426     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02487     Document Type: Article

References (44)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):e442.
2. World Health Organization. The global burden of disease 2004 update. Geneva: WHO; 2008. http://www.who.int/healthinfo/global_burden _disease/GBD_report_2004update_full.pdf. Accessed November 4, 2013.
3. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142(4):233-239.
4. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, et al. Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study. Clin Respir J 2011;5(1):44-9.
5. McGarvey LP, Magder S, Burkhart D, Kesten S, Liu D, Manuel RC, Niewoehner DE. Cause-specific mortality adjudication in the UPLIFT COPD trial: findings and recommendations. Respir Med 2012;106(4):515-21.
6. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the first National Health and Nutrition Examination Survey follow up study. Thorax 2003;58(5):388-393.
7. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171(6):591-597.
8. Nizet TA, van den Elshout FJ, Heijdra YF, van de Ven MJ, Mulder PG, Folgering HT. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest 2005;127(6):1904-1910.
9. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004;23(1):28-33.
10. Kent BD, Eltayeb EE, Woodman A, Mutwali A, Nguyen HT, Stack AG. The impact of chronic obstructive pulmonary disease and smoking on mortality and kidney transplantation in end-stage kidney disease. Am J Nephrol 2012;36(3):287-295.
11. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121(5):1434-1440.
12. Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006;173(12): 1326-1334.
13. Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD 2010;7(5):375-382.
14. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 15:186(2):155-61.
15. Hu G, Zhou Y, Tian J, Yao W, Li J, Li B, Ran P. Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest 2010;138(1): 20-31.
16. Mikkelsen RL, Middelboe TP, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychianty 2004;58(1):65-70.
17. Cuijpers P, Schoevers RA. Increased mortality in depressive disorders: a review. Curr Psychiatry Rep 2004;6(6):430-437.
18. Gallo JJ, Bogner HR, Morales KH, Post EP, Lin JY, Bruce ML. The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial. Ann Intern Med 2007; 146(10):689-698.
19. Mykletun A, Bjerkeset O, Øverland S, Prince M, Dewey M, Stewart R. Levels of anxiety and depression as predictors of mortality: the HUNT study. Br J Psychiatry 2009;195(2):118-125.
20. de Voogd JN, Wempe JB, Postema K, van Sonderen E, Ranchor AV, Coyne JC, Sanderman R. More evidence that depressive symptoms predict mortality in COPD patients: is type D personality an alternative explanation? Ann Behavior Med 2009;38(2):86-93.
21. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61(11):935-939.
22. Lou P, ZhuY, Chen P, Zhang P, Yu J, Zhang N, et al. Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study. BMC Public Health 2012;12:287.
23. Global initiative for chronic obstructive pulmonary disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Revised 2011. http://www. goldcopd.org/uploads/users/files/GOLD_Report_2011_Jan21.pdf. Accessed November 4, 2013.
24. Yumin ZH, Guoping H, Dali W, Shaoyi W, Yujun W, Zhigang L, et al. Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial. BMJ 2010; 341:c6387.
25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361-370.
26. Zheng LL, Wang YL, Li HL. Application of hospital anxiety and depression scale in general hospital: an analysis in reliability and validity. Shanghai Archiv Psychiatr 2003;15:264-266.
27. Zhang L, Lou P, Zhu Y, Chen P, Zhang P, Yu J, et al. Impact of risk factors, activities and psychological disorders on the health of patients with chronic obstructive pulmonary disease in China: a crosssectional study. BMC Public Health 2013;13:627. DOI: 10.1186/ 1471-2458-13-627.
28. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152(3):1107-1136.
29. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-586.
30. American Thoracic Society Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166(1):111-117.
31. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.
32. Rothman KJ, Greenland S, Lash T L. Modern epidemiology, 3rd edition. Philadelphia: Lippincott Williams & Wilkins; 2008.
33. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3(5):452-456.
34. Knol MJ, VanderWeele TJ, Groenwold RHH, Klungel OH, Rovers MM, GrobbeeDE. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011;26(6):433-438.
35. Cole MG. Does depression in older medical inpatients predict mortality? A systematic review. Gen Hosp Psychiatry 2007;29(5): 425-430.
36. Saz P, Dewey ME. Depression, depressive symptoms and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry 2001;16(6):622-630.
37. Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brøndum E, Bakke P, Janson C. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis 2012;7:571-576.
38. Hill K, Geist R, Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J 2008;31(3):667-677.
39. Glass RM. Blue mood, blackened lungs. Depression and smoking. JAMA 1990;264(12):1583-1584.
40. Wagena EJ, van Amelsvoort LG, Kant I, Wouters EF. Chronic bronchitis, cigarette smoking, and the subsequent onset of depression and anxiety: results from a prospective population-based cohort study. Psychosom Med 2005;67(4):656-660.
41. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG Jr. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992;146(5 Pt 1): 1345-1348.
42. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet 2001; 357(9272):1929-1932.
43. Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med 2006;100(1):87-93.
44. Patton GC, Hibbert M, Rosier MJ, Carlin JB, Caust J, Bowes G. Is smoking associated with depression and anxiety in teenagers? Am J Public Health 1996;86(2):225-230.